Search - Sphingotec

81. sphingotec transforms into end-to-end diagnostic solutions provider and exclusively represents Nexus Dx IB10 immunoassay portfolio

The German diagnostics company sphingotec GmbH (Hennigsdorf, Germany) today announced that through its network of regional and local distribution partners it will exclusively offer the Nexus Dx IB10…

82. sphingotec’s endothelial function biomarker bio-ADM® predicts need for organ support in general ICU patient population

Diagnostics company SphingoTec GmbH ("sphingotec", Hennigsdorf, Germany) today announced a publication in Critical Care1 with data on 2,000 ICU patients demonstrating that sphingotec‘s…

83. sphingotec’s biomarker penKid® predicts septic acute kidney injury at time of admission to emergency department

Diagnostics company SphingoTec GmbH ("sphingotec", Hennigsdorf Germany) today reported on the publication of novel study results of its proprietary kidney function biomarker penKid® in BMC…

84. sphingotec’s proprietary biomarker bio-ADM® detects residual congestion in patients with heart failure

Diagnostics company SphingoTec GmbH (sphingotec) today announced the publication of new study results in the European Journal of Heart Failure demonstrating that its proprietary endothelial function…

85. Proenkephalin a 119–159 (penKid) – a novel biomarker for acute kidney injury in sepsis: an observational study

Rosenqvist M.

86. One-year prognosis of kidney injury at discharge from the ICU: A multicenter observational study

Legrand M.

87. Proenkephalin and prognosis in heart failure with preserved ejection fraction: a GREAT network study

Kanagala P.

88. Proenkephalin, an opioid system surrogate, as a novel comprehensive renal marker in heart failure

Emmens J. E.

89. Adrenomedullin in heart failure: pathophysiology and therapeutic application

Voors A. A.

90. Bio-adrenomedullin as a marker of congestion in patients with new-onset and worsening heart failure

ter Maaten J. M.